Tag Archives: Stefan Oelrich

Bayer Invests $250 Million in Berkeley Cell Therapy Plant for Parkinson’s Disease Treatment

(IN BRIEF) Bayer has invested $250 million in a new cell therapy production plant in Berkeley, California, USA. This investment aims to support the production of materials for clinical trials and potential commercial launches of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), an … Read the full press release

Bayer to use Mammoth’s CRISPR systems for the development of vivo gene-editing therapies

Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems / Mammoth to receive upfront payment of USD 40 million, and potential future milestone payments of more … Read the full press release